Close this search box.

7th DDS Summit in Boston (online), June 8-9

Pivot Park Screening Centre (PPSC) will be one of the sponsors of the 7th edition of “Drug Discovery Strategic Summit” (DDSS). This edition, hosted from Boston,  highlights the advances in current and emerging technologies & challenges that includes opportunities and challenges amidst COVID-19 pandemic, target validation strategies for the discovery & development, novel drug designing approaches, AI and ML.

DDSS provides an exceptional platform in the field of drug discovery which covers everything from target identification to preclinical operations. Over the course of two days of the 7th DDSS there will be a great knowledge sharing opportunity and the possibility to meet the right professionals for your future business partnerships.

As a valued partner of DDSS, Pivot Park Screening Centre will deliver, on Tuesday 8th of June, a presentation about “Current and future applications of Mass Spectrometry technology in early drug discovery”, in cooperation with Bruker Daltonics and CeMOS.

Thursday 8 June, 16:00 hrs. – 18:00 hrs. CET
Current and future applications of Mass Spectometry technology in early drug discovery

During this session the presenters will go into detail about the following topics:

16:00 AM – 16:15 AM CET “Conventional frameworks for high-quality hit finding: Lessons learnt from HTS assay development” by Dr. Saman Honarnejad  Director Drug Discovery at Pivot Park Screening Centre
16:15 AM – 16:40 AM CET “Accelerating the Drug Discovery Process by Label-free Ultrahigh-Throughput Screening based on MALDI Mass Spectrometry.” By Dr. Arndt Asperger  Senior Scientist at Bruker Daltonics
16:40 AM – 17:05 AM CET “Hit discovery by label-free mass spectrometry in ultra-high throughput screening (uHTS) by Dr. Freek Janssen  Senior Scientist at Pivot Park Screening Centre
17:05AM – 17:30 AM CET “Label-free Cell Assays of Compound Uptake and Drug Action using MALDI-TOF Mass Spectrometry” by Prof. Carsten Hopf  Head of CeMOS R&D Center, Mannheim Technical University.
17:30 AM – 17:45 AM CET “A Real-Time Perspective on Binding: Surface Plasmon Resonance as Orthogonal Approach.” By Dr. Cyrill Brunner Application Specialist SPR at Bruker Daltonics
17:45 AM – 18:00 PM CET  Q & A Session

More information about the 7th DDS event in Boston, visit


Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.